Risk Factors for Recurrence of Clostridium Difficile-Associated Diarrhoea

Hepato-Gastroenterology

Volumn 60, Issue 126, 2013, Pages 1351-1354

  Abdel Samie, Ahmed ^a   Traub, Marc ^a   Bachmann, Klaus ^a   Kopischke, Karolin ^a   Theilmann, Lorenz ^a  

^a Pforzheim Hospital   (Germany)

Author keywords

Clostridium difficile associated diarrhoea; Proton pump inhibitors; relapse

Indexed keywords

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE COURSE; FEMALE; GASTROENTEROLOGY; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INFECTION RISK; LEUKOCYTOSIS; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; TERTIARY HEALTH CARE;

AGED; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84885706759     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12588     Document Type: Article

References (23)

1. McFarland LV, Mulligan ME, Kwork RY, Stamm WE: Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320:204-210. (Pubitemid 19034145)
2. Fekety R, McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Mulligan ME: Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 1997; 24:324-333. (Pubitemid 27096783)
3. McFarland LV, Surawicz CM, Rubin M, Fekety R, Elmer GW, Greenberg RN: Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol 1999; 20:43-50.
4. Jung KS, Park JJ, Chon YE, et al.: Risk factors for treatment failure and recurrence after metronidazole treatment for Clostridium difficile-associated diarrhea. Gut Liver 2010; 4:332-337.
5. Cadena J, Thompson GR, Patterson JE, Nakashima B, Owens A, Echevarria K, Mortensen EM: Clinical predictors and risk factors for relapsing Clostridium difficile infection. Am J Med Sci 2010; 339:350-355.
6. Moshkowitz M, Ben-Baruch E, Kline Z, Shimoni Z, Niven M, Konikoff F: Risk factors for severity and relapse of pseudomembranous colitis in an elderly population. Colorectal Dis 2007; 9:173-177. (Pubitemid 46111602)
7. Kim JW, Lee KL, Jeong JB, Kim BG, Shin S, Kim JS, Jung HC, Song IS: Proton pump inhibitors as a risk factor for recurrence of clostridium-difficile- associated diarrhea. World J Gastroenterol 2010; 28:3573-3677.
8. Pepin J, Routhier S, Gagnon S, Brazeau I: Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. CID 2006; 42:758-764. (Pubitemid 43363928)
9. Clements AC, Magalhães RJ, Tatem AJ, Paterson DL, Riley TV: Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. Lancet Infect Dis 2010; 10:395-404.
10. Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, Godin D, Bourassa C: Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, Canada. CID 2005; 40:1591-1597. (Pubitemid 40720808)
11. Maroo S, Lamont JT: Recurrent Clostridium difficile. Gastroenterology 2006; 130:1311-1316.
12. Choi HK, Kim KH, Lee SH, Lee SJ: Risk factors for recurrence of Clostridium difficile infection: effect of vancomycin-resistant enterococci colonization. J Korean Med Sci 2011; 26:859-864.
13. Drekonja DM, Amundson WH, Decarolis DD, Kuskowski MA, Lederle FA, Johnson JR: Antimicrobial use and risk for recurrent Clostridium difficile infection. Am J Med 2011; 124:1081, e. 1-7.
14. Garey KW, Sethi S, Yadav Y, DuPont HL: Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect 2008; 70:298-304.
15. Deshpande A, Pant C, Jain A, Fraser TG, Rolston DD: Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence. Curr Med Res Opin 2008; 24:329-33. (Pubitemid 351294381)
16. Eddi R, Malik MN, Shakov R, Baddoura WJ, Chandran C, Debari VA: Chronic kidney disease as a risk factor for Clostridium difficile infection. Nephrology (Carlton) 2010; 15:471-475.
17. Yousuf K, Saklayen MG, Markert RJ, Barde CJ, Gopalswamy N: Clostridium difficile-associated diarrhea and chronic renal insufficiency. South Med J 2002; 95:681-683. (Pubitemid 34774462)
18. Cunney RJ, Magee C, McNamara E, Smyth EG, Walshe J: Clostridium difficile colitis associated with chronic renal failure. Nephrol Dial Transplant 1998; 13:2842-2846. (Pubitemid 28479532)
19. Jacobson BC, Ferris TG, Shea TL, Mahlis EM, Lee TH, Wang TC: Who is using chronic acid suppression therapy and why? Am J Gastroenterol 2003; 98:51-58. (Pubitemid 36135169)
20. Deshpande A, Pant C, Pasupuleti V, Rolston DD, Jain A, Deshpande N, Thota P, Sierra TJ, Hernandez AV: Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. Clin Gastroenterol Hepatol 2012; 10:225-233.
21. Stevens V, Dumyati G, Brown J, Wijngaarden E: Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure. Pharmacoepidemiol Drug Saf 2011; 20(10):1035-1042.
22. Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA: Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med 2010; 170(9):772-778.
23. Bavishi C, Dupont HL: Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther 2011; 34(11-12):1269-1281.